Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 104 entries
View as:

Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03670342 Org: User:
Start: 08/20/15 End: 04/15/19 Due: 04/15/20

SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)

Phase: N/A Priority: Normal
NCT ID: NCT05724264 Org: User:
Start: 07/21/22 End: 12/31/29 Due: 12/31/30

Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02408497 Org: User:
Start: 04/30/15 End: 12/31/18 Due: 12/31/19

Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT03792867 Org: User:
Start: 07/23/18 End: 03/31/24 Due: 03/31/25

Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care

Phase: N/A Priority: Normal
NCT ID: NCT06244953 Org: User:
Start: 08/14/24 End: 10/31/27 Due: 10/31/28

Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05929885 Org: User:
Start: 08/30/23 End: 02/28/26 Due: 02/28/27

Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers

Phase: N/A Priority: Normal
NCT ID: NCT04946968 Org: User:
Start: 08/24/21 End: 05/31/27 Due: 05/31/28

Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients

Phase: N/A Priority: Normal
NCT ID: NCT05377034 Org: User:
Start: 10/26/22 End: 10/26/26 Due: 10/26/27

Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells

Phase: N/A Priority: Normal
NCT ID: NCT01022723 Org: User:
Start: 10/31/09 End: 12/31/18 Due: 12/31/19

Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole

Phase: N/A Priority: Normal
NCT ID: NCT05286437 Org: User:
Start: 02/15/23 End: 09/30/27 Due: 09/30/28

Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04340024 Org: User:
Start: 09/30/15 End: 12/31/26 Due: 12/31/27

Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00702481 Org: User:
Start: 04/28/08 End: 09/03/19 Due: 09/03/20

The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC

Phase: N/A Priority: Normal
NCT ID: NCT04664829 Org: User:
Start: 10/01/20 End: 09/30/25 Due: 09/30/26

A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR

Phase: N/A Priority: Normal
NCT ID: NCT01570296 Org: User:
Start: 10/03/11 End: 12/17/18 Due: 12/17/19

Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03093831 Org: User:
Start: 07/08/16 End: 07/17/20 Due: 07/17/21

Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin

Phase: N/A Priority: Normal
NCT ID: NCT04620954 Org: User:
Start: 10/07/20 End: 07/31/22 Due: 07/31/23

Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04118114 Org: User:
Start: 09/03/19 End: 12/31/25 Due: 12/31/26

Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00702182 Org: User:
Start: 04/30/08 End: 10/31/12 Due: 10/31/13

Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06194084 Org: User:
Start: 02/01/23 End: 12/30/25 Due: 12/30/26

Breast Cancer Exercise Intervention Study

Phase: N/A Priority: Normal
NCT ID: NCT05957068 Org: User:
Start: 07/01/23 End: 05/31/33 Due: 05/31/34

Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)

Phase: N/A Priority: Normal
NCT ID: NCT04965259 Org: User:
Start: 04/15/21 End: 12/21/26 Due: 12/21/27

Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00870532 Org: User:
Start: 06/30/08 End: 09/30/13 Due: 09/30/14

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00687648 Org: User:
Start: 05/31/08 End: - Due: -

Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry

Phase: N/A Priority: Normal
NCT ID: NCT03233360 Org: User:
Start: 04/17/17 End: 12/31/20 Due: 12/31/21

ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin

Phase: N/A Priority: Normal
NCT ID: NCT02435927 Org: User:
Start: 08/31/14 End: 06/30/21 Due: 06/30/22